Arrowhead Pharmaceuticals has dosed the first participants in its Phase I/IIa clinical trial of ARO-DIMER-PA, an investigational dual functional RNAi...
Arrowhead Pharmaceuticals has dosed the first participants in its Phase I/IIa clinical trial of ARO-DIMER-PA, an investigational dual functional RNAi...
Insilico Medicine has entered a strategic partnership with Qilu Pharmaceutical to develop treatments for cardiometabolic diseases.The post Insilico and Qilu...
Myra Vision has enrolled the first patient in the ADAPT clinical trial assessing its Calibreye TGT surgical system in the...
Neurocrine Biosciences has started a Phase II clinical trial of NBI-1065890, a selective VMAT2 inhibitor, in adults with TD.The post...
Eisai and Biogen have announced that the US FDA has accepted for review the sBLA submitted by the former for...
The University of Nottingham has announced a collaboration with Italy’s Aboca and specialists from the University’s Sir Peter Mansfield Magnetic...
IGC Pharma has expanded its CALMA Phase II clinical trial by adding Integrative Clinical Trials, based in Brooklyn, New York,...
Daiichi Sankyo and AstraZeneca’s Enhertu has received approval from China’s NMPA for adult patients with locally advanced or metastatic HER2...
Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.